<SEC-DOCUMENT>0001683168-25-007478.txt : 20251009
<SEC-HEADER>0001683168-25-007478.hdr.sgml : 20251009
<ACCEPTANCE-DATETIME>20251009163056
ACCESSION NUMBER:		0001683168-25-007478
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20251003
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251009
DATE AS OF CHANGE:		20251009

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sonoma Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001367083
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				680423298
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33216
		FILM NUMBER:		251385436

	BUSINESS ADDRESS:	
		STREET 1:		5445 CONESTOGA COURT, SUITE 150
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		800-759-9305

	MAIL ADDRESS:	
		STREET 1:		5445 CONESTOGA COURT, SUITE 150
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oculus Innovative Sciences, Inc.
		DATE OF NAME CHANGE:	20060622
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sonoma_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:SNOA="http://sonomapharma.com/20251003">
<head>
     <title>Sonoma Pharmaceuticals, Inc. 8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_SNOA_sonomapharma.com_20251003 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20251003_20251003 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001367083 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000004" name="dei:EntityCentralIndexKey">0001367083</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="snoa-20251003.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-10-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001367083</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-03</xbrli:startDate>
        <xbrli:endDate>2025-10-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 12pt"><b>FORM&#160;<span id="xdx_907_edei--DocumentType_c20251003__20251003_zguUN3FBrIoc"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Pursuant to Section&#160;13 OR 15(d)&#160;of
The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of
earliest event reported) <b><span id="xdx_900_edei--DocumentPeriodEndDate_c20251003__20251003_zFJz16qPwdfi"> <ix:nonNumeric contextRef="AsOf2025-10-03" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">October 3,
2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_902_edei--EntityRegistrantName_c20251003__20251003_zd7WuJdVWjag" style="font-size: 12pt"><b><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000011" name="dei:EntityRegistrantName">SONOMA
PHARMACEUTICALS, INC.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20251003__20251003_zdFrTxrSOc76"><ix:nonNumeric contextRef="AsOf2025-10-03" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityFileNumber_c20251003__20251003_zJFe6MVn5vJ7"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000013" name="dei:EntityFileNumber">001-33216</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center">&#160;</td>
    <td style="vertical-align: top; width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20251003__20251003_zLrVwTBiPjSd"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000014" name="dei:EntityTaxIdentificationNumber">68-0423298</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(State or other jurisdiction</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Commission</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(IRS Employer</span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">of incorporation)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">File Number)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20251003__20251003_zr0Wl6YQvhJ3"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000015" name="dei:EntityAddressAddressLine1">5445
Conestoga Court</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressAddressLine2_c20251003__20251003_zNR1lpIChF6"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite
150</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20251003__20251003_zaQZ6JgZeK5k"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000017" name="dei:EntityAddressCityOrTown">Boulder</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20251003__20251003_z1CcuuIZ3Kod"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000018" name="dei:EntityAddressStateOrProvince">CO</ix:nonNumeric></span> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20251003__20251003_z94GIoeh6GWb"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000019" name="dei:EntityAddressPostalZipCode">80301</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_905_edei--CityAreaCode_c20251003__20251003_zkSEctXKxQv5"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000020" name="dei:CityAreaCode">(800)</ix:nonNumeric></span> <span id="xdx_90E_edei--LocalPhoneNumber_c20251003__20251003_zBzSdMlX8rNk"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000021" name="dei:LocalPhoneNumber">759-9305</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Not applicable.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration: underline">see</span>&#160;General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt"><span id="xdx_90D_edei--WrittenCommunications_c20251003__20251003_ztp1BhxatpFc"><ix:nonNumeric contextRef="AsOf2025-10-03" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt"><span id="xdx_901_edei--SolicitingMaterial_c20251003__20251003_z3IFLy6gVTnd"><ix:nonNumeric contextRef="AsOf2025-10-03" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt"><span id="xdx_908_edei--PreCommencementTenderOffer_c20251003__20251003_zBK9fmZB6Rjk"><ix:nonNumeric contextRef="AsOf2025-10-03" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20251003__20251003_zTvHNEb7wZdk"><ix:nonNumeric contextRef="AsOf2025-10-03" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 36%; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 28%; text-align: center"><span style="font-size: 10pt">Trading symbol(s)</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 36%; text-align: center"><span style="font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_903_edei--Security12bTitle_c20251003__20251003_zne6YcUqm2Ya"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000026" name="dei:Security12bTitle">Common
    Stock</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20251003__20251003_zmbnuLwH9wee"><ix:nonNumeric contextRef="AsOf2025-10-03" id="Fact000027" name="dei:TradingSymbol">SNOA</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">The <span id="xdx_90C_edei--SecurityExchangeName_c20251003__20251003_z69ybkR9QxRf"><ix:nonNumeric contextRef="AsOf2025-10-03" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or
Rule&#160;12b-2&#160;of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2). Emerging growth company&#160;<span id="xdx_901_edei--EntityEmergingGrowthCompany_c20251003__20251003_zHwymWyEIT5"><ix:nonNumeric contextRef="AsOf2025-10-03" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 5.02.</b></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="text-decoration: underline">Amended and Restated Employment Agreement with our Chief Executive
Officer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Effective October 3, 2025, we entered into an amended and restated
employment agreement with our Chief Executive Officer, Amy Trombly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Under the amended and restated agreement, we agreed to pay Ms. Trombly
a base salary of $475,000 per annum. Ms. Trombly will be eligible to receive a target annual bonus of 50% of her base salary, which shall
be in the discretion of the Compensation Committee. Consistent with best practices, the definition of Cause was expanded to include material
failure by Ms. Trombly to comply with the Company&#8217;s written policies or rules, if such failure is reasonably likely to cause material,
reputational or financial harm to the Company. Also consistent with best practices, the definition of Good Reason excludes base salary
reductions up to 10% as applied consistently to similarly-situated executives. Good Reason also excludes the failure by a successor to
the Company to assume the terms of the amended and restated agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">In the event of termination without Cause or for Good Reason, Ms.
Trombly&#8217;s severance payment is to be paid in accordance with regular payroll rather than as a lump sum payment, consistent with
best practices, and COBRA reimbursement is extended to up to twelve months following termination for Ms. Trombly, her spouse or domestic
partner and her dependents. In the event of termination without Cause or for Good Reason in connection with a Change in Control, Ms. Trombly&#8217;s
severance payment is increased to two times her annual base salary and two times her target annual bonus, and COBRA reimbursement is extended
to up to twenty-four months following termination for Ms. Trombly, her spouse or domestic partner and her dependents. In the event of
termination due to death or disability, COBRA reimbursement is extended to up to twelve months following termination for Ms. Trombly,
her spouse or domestic partner and her dependents.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">The mutual notice period for termination is extended to 90 days,
and vested equity awards may be exercised for up to 24 months following termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">Consistent with best practices, the amended and restated
agreement does not require the Company to reimburse Ms. Trombly in the event of any 409A excise taxes, and the non disparagement covenant
was updated to comply with current Colorado law. All other material terms of the amended and restated agreement remain unchanged from
her prior employment agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The foregoing description of the Amended and Restated
Employment Agreement is not complete and is qualified in its entirety by reference to the full text of the Amended and Restated Employment
Agreement, a copy of which is filed herewith as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Departure of Chief Operating Officer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 3, 2025, our Executive Vice President
and Chief Operating Officer, Bruce Thornton, notified us of his intent to retire from his position with the Company effective
December 2, 2025, and we have determined to eliminate the position of Chief Operating Officer upon Mr. Thornton&#8217;s departure.
Mr. Thornton has agreed to assist us with transitioning his responsibilities over the next two months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with Mr. Thornton&#8217;s termination,
we will pay him severance consisting of $300,000, contingent upon his execution of a general release of claims against the Company. He
will also be entitled to up to twelve months&#8217; COBRA reimbursement for himself and his dependents. All outstanding time-based equity-based
compensation awards will become fully vested and all outstanding performance-based equity compensation awards will remain outstanding
and will vest or be forfeited in accordance with the terms of the applicable award agreements. Mr. Thornton&#8217;s Executive&#8217;s
outstanding and vested equity awards shall remain exercisable for 18 months following termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Mr. Thornton has served as our Chief Operating Officer
since April 2020 and previously as our Executive Vice President for International Operations and Sales and General Manager for U.S. operations
since March 2004. We thank Mr. Thornton for his many years of dedicated service and wish him the best in his future endeavors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01.</b></span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(d)&#160;<span style="text-decoration: underline">Exhibits</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 90%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="sonoma_ex1001.htm">Amended and Restated Employment Agreement by and between the Company and Amy Trombly, dated October 3, 2025.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>104</td>
    <td>&#160;</td>
    <td>Cover Page Interactive Data File (formatted in Inline XBRL in Exhibit 101).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SONOMA PHARMACEUTICALS, INC.</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 70%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: October 9, 2025</span></td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&#160;</span></td>
    <td style="vertical-align: top; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Amy Trombly</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Name:</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Title:</p></td>
    <td style="border-top: black 1pt solid; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amy Trombly<br/>
Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 3; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fk1DRemjRYtYRYqIr8FuJdhmyyb+HclbGlvEZWFZZr4ZIUYip5VpkOG0KAs4YNs12iOUWCOjPWNwZOtNCuGWeDHOs7a+f39gRoHBwEzHSukg9Na7cVilIJOJjCcqATlP4xnstyL66hnZ2lRovdENaFvBnqljg17za0g46CdZal991RHZGbIpxGM5yG9QMlawo7t+EF8dFEUmolE/kciZbl1wLZ8e7ZeEZYNtqHMD/d/oAwaoSo0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>sonoma_ex1001.htm
<DESCRIPTION>AMENDED AND RESTATED EMPLOYMENT AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AMENDED AND RESTATED EMPLOYMENT AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This AMENDED AND RESTATED EMPLOYMENT
AGREEMENT (this &ldquo;<U>Agreement</U>&rdquo;) is entered into by and between Amy Trombly (the &ldquo;<U>Executive</U>&rdquo;), and Sonoma
Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo;), as of October 3, 2025 (the &ldquo;<U>Effective Date</U>&rdquo;).
This Agreement replaces that certain employment agreement dated as of June 16, 2023, and entered into by and between the Executive and
the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Corporation
desires that the Executive continue to be employed by the Corporation as its Chief Executive Officer and to serve as a member of the Board
of Directors of the Corporation, and to carry out the duties and responsibilities described below, all on the terms and conditions set
forth herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Executive
is willing to accept and continue such employment on such terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in consideration
of the foregoing premises and the mutual covenants and promises of the parties herein, the receipt and sufficiency of which are hereby
acknowledged by each of the parties, the Corporation and the Executive hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1. <U>Employment and Duties</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.1 <U>Position</U>. On the terms
and subject to the conditions set forth herein, the Corporation agrees to employ Executive as its Chief Executive Officer until such time
as the employment relationship ends or is terminated by either Party pursuant to <I>Section 2</I>. Executive does hereby accept and agree
to such employment, on the terms and conditions expressly set forth in this Agreement. Executive shall also serve as a member of the Board
of Directors of the Corporation (the &ldquo;<U>Board</U>&rdquo;) and may be required to serve as an officer or director of any affiliate
of the Corporation for no additional compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.2 <U>Duties</U>. During the
Term of Employment (as defined in <I>Section 2</I>), Executive shall serve the Corporation as its Chief Executive Officer and as a member
of the Board of Directors of the Corporation. Executive and shall, without limitation and without limiting Executive&rsquo;s other duties
to the Corporation, and without limiting the authority of the Corporation&rsquo;s Board of Directors, be responsible for the general supervision,
direction and control of the business and affairs of the Corporation and have such other duties and responsibilities as the Board shall
designate that are consistent with Executive&rsquo;s position as Chief Executive Officer of the Corporation. Executive shall perform all
of such duties and responsibilities in accordance with the legal directives of the Board and in accordance with the practices and policies
of the Corporation as in effect from time to time throughout the Term of Employment (including, without limitation, the Corporation&rsquo;s
insider trading and ethics policies, as they may change from time to time). While employed as Chief Executive Officer of the Corporation,
Executive shall report exclusively to the Board. Throughout the Term of Employment, Executive shall not serve on the boards of directors
or advisory boards of any other entity, except for any wholly or majority owned subsidiaries of the Corporation, unless such service is
expressly approved by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.3 <U>No Other Employment; Minimum
Time Commitment</U>. Throughout the Term of Employment, the Executive shall both (i) devote substantially all of the Executive&rsquo;s
business time, energy and skill to the performance of the Executive&rsquo;s duties for the Corporation, and (ii) hold no other job. The
Executive agrees that any investment or direct involvement in, or any appointment to or continuing service on the board of directors or
similar body of, any corporation or other entity, other than wholly or majority owned subsidiaries of the Corporation, must be first approved
in writing by the Corporation. The foregoing provisions of this <I>Section 1.3</I> shall not prevent the Executive from investing in non-competitive,
publicly-traded securities to the extent permitted by <I>Section 6(b)</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.4 <U>No Breach of Contract</U>.
Executive hereby represents to the Corporation that the execution and delivery of this Agreement by the Executive and the Corporation
and the performance by the Executive of the Executive&rsquo;s duties hereunder shall not constitute a breach of, or otherwise contravene,
the terms of any other agreement or policy to which the Executive is a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.5 <U>Place of Performance</U>.
The principal place of Executive&rsquo;s employment shall be the Corporation&rsquo;s offices located in Boulder, Colorado, though such
principal place of employment of the Executive may be moved from time to time upon mutual agreement by the Executive and the Corporation.
The Executive agrees that the Executive will be regularly present at the Corporation&rsquo;s principal executive offices, or such other
location as the parties may designate, and that the Executive may be required to travel from time to time in the course of performing
the Executive&rsquo;s duties for the Corporation. The Corporation acknowledges that Executive&rsquo;s principal place of residence is
and will remain during the Term of Employment, Colorado.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2. <U>At-Will Employment, Term of Employment</U>.
The &ldquo;<U>Term of Employment</U>&rdquo; shall commence on the Effective Date, and shall continue in full force until the Termination
Date pursuant to <I>Section 5.9</I>. The Parties agree that Executive&rsquo;s employment with the Corporation will be &ldquo;at-will&rdquo;
employment and may be terminated at any time with or without cause in accordance with <I>Section 5</I>. This Agreement shall govern the
terms of Executive&rsquo;s employment hereunder on and after the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3. <U>Compensation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.1 <U>Base Salary</U>. As of
the Effective Date and during the Term of Employment, the Corporation shall pay to the Executive a base salary at the rate of $39,584
per month ($475,000 per annum), subject to increase (but not decrease) by the Board (the &ldquo;<U>Base Salary</U>&rdquo;). The Executive&rsquo;s
Base Salary shall be paid in accordance with the Corporation&rsquo;s regular payroll practices in effect from time to time, but no less
frequently than monthly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">3.2&nbsp;<U>Annual
Bonus</U>. For each fiscal year during the Term of Employment, Executive shall be eligible to receive a target annual bonus (the &ldquo;Annual
Bonus&rdquo;) of 50% of Base Salary. The decision to provide any annual bonus and the amount and terms of any Annual Bonus shall be in
the sole and absolute discretion of the Compensation Committee of the Board. Executive must be employed by the Corporation on the day
that any Annual Bonus is paid. The Board of Directors or the Compensation Committee, as appropriate, may in its sole discretion agree
to pay a pro rata or full Annual Bonus, and if such Annual Bonus is granted, then determine the amount, form and payment schedule.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.3 <U>Equity</U>. During the
Term of Employment, Executive shall be eligible to participate in the Corporation&rsquo;s equity-based incentive programs in effect at
the time, subject to the terms of such plans, as determined by the Board or the Compensation Committee, in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.4 <U>Indemnification.</U> (a)
In the event that the Executive is made a party or threatened to be made a party to any action, suit, or proceeding, whether civil, criminal,
administrative or investigative (a &ldquo;<U>Proceeding</U>&rdquo;), other than any Proceeding initiated by the Executive or the Corporation
related to any contest or dispute between the Executive and the Corporation or any of its affiliates with respect to this Agreement or
the Executive&rsquo;s employment hereunder, by reason of the fact that the Executive is or was a director or officer of the Corporation,
or any affiliate of the Corporation, or is or was serving at the request of the Corporation as a director, officer, member, employee or
agent of another corporation or a partnership, joint venture, trust or other enterprise, the Executive shall be indemnified and held harmless
by the Corporation to the maximum extent permitted under applicable law and the Corporation&rsquo;s articles and bylaws, as may be amended
from time to time, from and against any liabilities, costs, claims and expenses, including all costs and expenses incurred in defense
of any Proceeding (including attorneys&rsquo; fees).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) During the Term of Employment
and for a period of six (6) years thereafter, the Corporation or any successor to the Corporation shall purchase and maintain, at its
own expense, directors&rsquo; and officers&rsquo; liability insurance providing coverage to the Executive on terms that are no less favorable
than the coverage provided to other directors and similarly situated executives of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.5 <U>Clawback Provisions</U>.
Any incentive-based compensation, or any other compensation, paid to the Executive pursuant to this Agreement or any other agreement or
arrangement with the Corporation which is subject to recovery under any law, government regulation, stock exchange listing requirement,
or Company clawback policy, will be subject to such deductions and clawback as may be required to be made pursuant to such law, government
regulation, stock exchange listing requirement or Company policy (or any policy adopted by the Corporation pursuant to any such law, government
regulation or stock exchange listing requirement). The Corporation will make any determination for clawback or recovery in accordance
with any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">4. <U>Benefits</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.1 <U>Health and Welfare</U>.
During the Term of Employment, Executive shall be entitled to participate in all employee pension and welfare benefit plans and programs
made available by the Corporation to the Corporation&rsquo;s senior-level employees generally, as such plans or programs may be in effect
from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.2 <U>Reimbursement of Business
Expenses</U>. Executive is authorized to incur reasonable expenses in carrying out Executive&rsquo;s duties for the Corporation under
this Agreement and entitled to reimbursement for all such expenses Executive incurs during the Term of Employment in connection with carrying
out the Executive&rsquo;s duties for the Corporation, as approved by the Corporation&rsquo;s Chief Financial Officer and subject to the
Corporation&rsquo;s reasonable expense reimbursement policies in effect from time to time. Such expenses may include but are not limited
to travel, lodging and meals. The Corporation shall reimburse Executive to the extent required by the preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.3 <U>Vacation and Other Leave</U>.
During the Term of Employment, Executive shall accrue and be entitled to take paid vacation of 4 weeks per annum pro-rated in accordance
with the Corporation&rsquo;s standard vacation policies in effect from time to time, including the Corporation&rsquo;s policies regarding
vacation accruals, provided however, that Executive shall be able to accrue a maximum of two times of the annual vacation time. Executive
shall also be entitled to all other holiday and leave pay generally available to all other employees of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">5. <U>Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.1. <U>Termination</U>. Upon
termination of Executive&rsquo;s employment during the Term of Employment, Executive (or the Executive&rsquo;s estate and/or beneficiaries,
as the case may be) shall be entitled to the compensation and benefits described in this <I>Section 5 </I>and shall have no further rights
to any compensation or any other benefits from the Corporation or any of its affiliates. Notwithstanding any other provision contained
herein, all payments made in connection with Executive&rsquo;s Death shall be provided in a manner which is consistent with federal and
state law. The Corporation may deduct from all payments made hereunder, all applicable taxes and other appropriate deductions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.2. <U>Definitions</U>. For purposes
of this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) &ldquo;<U>Accrued Amounts</U>&rdquo;
shall mean:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 58.5pt">(i)&nbsp;&nbsp;any accrued but
unpaid Base Salary and accrued but unused vacation which shall be paid in the next regularly scheduled payroll following one (1) week
after termination; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(iii) reimbursement for unreimbursed
business expenses properly incurred by the Executive, which shall be subject to and paid in accordance with the Corporation&rsquo;s expense
reimbursement policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) &ldquo;<U>Change in Control</U>&rdquo;
shall mean the occurrence of any of the following after the Effective Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(i)&nbsp;&nbsp;one person (or more
than one person acting as a group) acquires ownership of stock of the Corporation that, together with the stock held by such person or
group, constitutes more than 50% of the total fair market value or total voting power of the stock of such corporation; provided that,
a Change in Control shall not occur if any person (or more than one person acting as a group) owns more than 50% of the total fair market
value or total voting power of the Corporation&rsquo;s stock and acquires additional stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(ii)&nbsp;&nbsp;a majority of the
members of the Board are replaced during any twelve-month period by directors whose appointment or election is not endorsed by a majority
of the Board before the date of appointment or election; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">(iii)&nbsp;&nbsp;the sale of all or substantially
all of the Corporation&rsquo;s assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 63pt">Notwithstanding the foregoing,
a Change in Control shall not occur unless such transaction constitutes a change in the ownership of the Corporation, a change in effective
control of the Corporation, or a change in the ownership of a substantial portion of the Corporation&rsquo;s assets under Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63pt; text-align: justify">For purposes of the definition of &ldquo;<U>Change
of Control</U>&rdquo;, the following definitions shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 63pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(i) The term &ldquo;person&rdquo;
shall mean any individual, corporation or other entity and any group as such term is used in Section 13(d) (3) or 14(d) (2) of the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(ii)&nbsp;&nbsp;Any person shall
be deemed to be the beneficial owner of any shares of capital stock of the Corporation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify">a. which that person owns directly whether
or not of record, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify">b. which that person has the right to acquire
pursuant to any agreement or understanding or upon exercise of conversion rights, warrants, or options, or otherwise, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify">c. which are beneficially owned, directly
or indirectly (including shares deemed owned through application of clause (b) above, by an &ldquo;affiliate&rdquo; or &ldquo;associate&rdquo;
(as defined in the rules of the Securities and Exchange Commission under the Securities Act of 1933, as amended) of that person, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 94.5pt; text-align: justify">d. which are beneficially owned, directly
or indirectly (including shares deemed owned through application of clause (b) above), by any other person with which that person or her
&ldquo;affiliate&rdquo; or &ldquo;associate&rdquo; (defined as aforesaid) has any agreement, arrangement, or understanding for the purpose
of acquiring, holding, voting or disposing of capital stock of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(iii)&nbsp;&nbsp;The outstanding
shares of capital stock of the Corporation shall include shares deemed owned through application of clause (ii) (b), (c), and (d) above,
but shall not include any other shares which may be issuable pursuant to any agreement or upon exercise of conversion rights, warrants
or options, or otherwise, but which are not actually outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">(c) &ldquo;<U>Cause</U>&rdquo; shall mean:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 49.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(i)&nbsp;&nbsp;the Executive&rsquo;s
willful failure to perform Executive&rsquo;s duties (other than any such failure resulting from incapacity due to physical or mental illness);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(ii)&nbsp;&nbsp;the Executive&rsquo;s
willful failure to comply with any valid and legal directive of the Board communicated to Executive in writing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(iii)&nbsp;&nbsp;the Executive&rsquo;s
willful engagement in dishonesty, illegal conduct or gross misconduct, which is, in each case, materially injurious to the Company Group;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(iv)&nbsp;&nbsp;the Executive&rsquo;s
embezzlement, misappropriation or fraud, whether or not related to the Executive&rsquo;s employment with the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(v)&nbsp;&nbsp;the Executive&rsquo;s
conviction of or plea of guilty or&nbsp;<I>nolo contendere</I>&nbsp;to a crime that constitutes a felony (or state law equivalent) or
a crime that constitutes a misdemeanor involving moral turpitude;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(vi)&nbsp;&nbsp;the Executive&rsquo;s
violation of a material policy of the Corporation that has been provided to Executive (documents made public on the Corporation&rsquo;s
website or through filings with the U.S. Securities and Exchange Commission are deemed provide to the Executive);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">(vii)&nbsp;&nbsp;the Executive&rsquo;s willful
unauthorized disclosure of Confidential Information (as defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 58.5pt">(viii)&nbsp;&nbsp;the Executive&rsquo;s
material breach of any material obligation under this Agreement or any other written agreement between the Executive and the Corporation;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 58.5pt">(ix)&nbsp;&nbsp;any material
failure by the Executive to comply with the Corporation&rsquo;s written policies or rules, as they may be in effect from time to time
during the Employment Term, if such failure causes, or is reasonably likely to cause, material, reputational or financial harm to the
Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt">For purposes of this provision,
no act or failure to act on the part of the Executive shall be considered &ldquo;willful&rdquo; unless it is done, or omitted to be done,
by the Executive in bad faith or without reasonable belief that the Executive&rsquo;s action or omission was in the best interests of
the Corporation. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the
advice of counsel for the Corporation shall be conclusively presumed to be done, or omitted to be done, by the Executive in good faith
and in the best interests of the Corporation. In all cases the Corporation shall notify the Executive in writing of the basis for any
for Cause termination by providing a detailed description of the alleged facts and circumstances giving rise to Cause. In addition, with
respect to clauses (i), (ii), (vi), (viii) and (ix) Executive shall be given a period of at least 30 days to cure and only if Executive
fails to cure within such time period will a termination be for Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT>&ldquo;<U>Disability</U>&rdquo;
shall mean the Executive&rsquo;s inability, due to physical or mental incapacity, to substantially perform her duties and responsibilities
under this Agreement, with or without reasonable accommodation, for 90 calendar days out of any three hundred sixty-five (365) calendar
day period, but only if the Executive is considered disabled within the meaning of Treasury Regulation section 1.409A-3(i)(4). Without
limiting the circumstances in which the Executive may be determined to be disabled as defined in Treasury Regulation section 1.409A-3(i)(4),
the Executive will be presumed to be disabled if determined to be totally disabled by the Social Security Administration or if determined
to be disabled in accordance with a disability insurance program, provided the definition of disability applied under such disability
insurance program complies with the requirements of Treasury Regulation section 1.409A-3(i)(4). Any question as to the existence of the
Executive&rsquo;s Disability as to which the Executive and the Corporation cannot agree shall be determined in writing by a qualified
independent physician mutually acceptable to the Executive and the Corporation. If the Executive and the Corporation cannot agree as to
a qualified independent physician, each shall appoint such a physician and those two physicians shall select a third who shall make such
determination in writing. The determination of Disability made in writing to the Corporation and the Executive shall be final and conclusive
for all purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e) &ldquo;<U>Good Reason</U>&rdquo;
shall mean the occurrence of any of the following, in each case during the Employment Term without the Executive&rsquo;s written consent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">(i)&nbsp;&nbsp;a reduction in the Executive&rsquo;s
then current Base Salary;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(ii)&nbsp;&nbsp; a relocation of
the Executive&rsquo;s principal place of employment by more than 50 miles, unless the new principal place of employment is closer to Executive&rsquo;s
principal residence; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">(iii)&nbsp;&nbsp;a material, adverse
change in the Executive&rsquo;s title, authority, duties or responsibilities (other than temporarily while the Executive is physically
or mentally incapacitated or as required by applicable law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt">The Executive cannot terminate
her employment for Good Reason unless she has provided written notice to the Corporation of the existence of the circumstances providing
grounds for termination for Good Reason within 30 business days of the initial existence of such grounds and the Corporation has had at
least 30 business days from the date on which such notice is provided to cure such circumstances. If the Executive does not terminate
her employment for Good Reason within 30 calendar days after the expiration of the cure period, then the Executive will be deemed to have
waived her right to terminate for Good Reason with respect to such grounds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.3. <U>Termination for Cause
or Without Good Reason</U>. In case of termination by the Corporation for Cause or by the Executive without Good Reason, Executive shall
be entitled to the Accrued Amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.4. <U>Termination without Cause
or for Good Reason</U>. In case of termination without Cause by the Corporation or for Good Reason by the Executive, Executive shall be
entitled to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(a)</FONT></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Accrued Amounts (paid as soon as practicable following such termination);</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 76.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT>
subject to the Executive&rsquo;s compliance with&nbsp;<I>Sections 6 through 11 </I>of this Agreement and her execution of a release of
claims in favor of the Corporation, its affiliates and their respective officers and directors in a form attached hereto (the &ldquo;Release&rdquo;)
and such Release becoming effective within the applicable time period set forth in the Release (the &ldquo;Release Execution Period&rdquo;),
the Executive shall be entitled to receive one times the sum of the Executive&rsquo;s annual Base Salary, which shall be paid in accordance
with regular payroll commencing within 30 calendar days following the Termination Date; provided the Release is effective and non-revocable;
further provided, however, that if such 30-day period spans two calendar years, payment of any amounts determined to be deferred compensation
subject to Section 409A of the Code shall be made or commence in the second calendar year;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT>
upon determination by the Corporation&rsquo;s Board of Directors or Compensation Committee, as appropriate, to be made in its sole discretion
as to whether to grant such bonus, a pro-rata Annual Bonus, and if such pro-rata Annual Bonus is granted, determine the amount, form and
payment schedule. For the avoidance of doubt, Executive shall not be entitled to any Annual Bonus solely for reason of termination, unless
the Board of Directors or the Compensation Committee, as appropriate, in its sole discretion awards a bonus to Executive;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(d)</FONT>
If the Executive timely and properly elects health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985
(&ldquo;COBRA&rdquo;), the Corporation shall reimburse the Executive for the monthly COBRA premium paid by the Executive for herself,
a spouse or domestic partner, if applicable, and her dependents. Such reimbursement shall be paid to the Executive on the 10th day of
the month immediately following the month in which the Executive timely remits the premium payment (&ldquo;COBRA Premium Reimbursements&rdquo;).
The Executive shall be eligible to receive such COBRA Premium Reimbursement until the earliest of: (i) the twelve-month anniversary of
the termination; (ii) the date the Executive is no longer eligible to receive COBRA continuation coverage; and (iii) the date on which
the Executive becomes eligible to receive substantially similar coverage from another employer or other source. Notwithstanding the foregoing,
if the Corporation&rsquo;s making payments under this <I>Section 5.4(d)</I> would violate the nondiscrimination rules applicable to non-grandfathered
plans under the Affordable Care Act (the &ldquo;ACA&rdquo;), or result in the imposition of penalties under the ACA and the related regulations
and guidance promulgated thereunder), the parties agree to reform this <I>Section 5.4(d)</I> in a manner as is necessary to comply with
the ACA;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt">(e) &nbsp;&nbsp;All outstanding
time-based equity-based compensation awards granted to the Executive during the Term of Employment shall become fully vested; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 76.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt">(f) &nbsp;&nbsp;All outstanding
performance-based equity compensation awards granted to the Executive during the Term of Employment shall remain outstanding and shall
vest or be forfeited in accordance with the terms of the applicable award agreements, if the applicable performance goals are satisfied.
The determination whether such performance goals are satisfied shall be in the sole discretion of the Compensation Committee or the Board,
as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.5. <U>Termination upon Change
in Control</U>. Notwithstanding any other provision contained herein, if the Executive&rsquo;s employment hereunder is terminated by the
Executive for Good Reason or without Cause (other than on account of the Executive&rsquo;s death or Disability), in each case within three
(3) months prior to (and contingent upon the occurrence of) or twelve (12) months following a Change in Control, the Executive shall be
entitled to receive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt">(a) &nbsp;&nbsp; the Accrued Amounts
(paid as soon as practicable following such termination);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(b)</FONT>subject
to the Executive&rsquo;s compliance with&nbsp;<I>Sections 6 through 11</I>&nbsp;of this Agreement and execution of a Release which becomes
effective by the end of the Release Execution Period, the Executive shall be entitled to receive a lump sum payment equal to two times
the sum of the Executive&rsquo;s annual Base Salary;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt"><FONT STYLE="display: inline-block; width: 0.5in; float: left; white-space:nowrap">(c)</FONT>Two
times the target Annual Bonus amount;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt">(d) &nbsp;&nbsp;If the Executive
timely and properly elects health continuation coverage under COBRA, the Corporation shall reimburse the Executive for the monthly COBRA
premium paid by the Executive for herself, a spouse or domestic partner, as applicable, and her dependents. Such reimbursement shall be
paid to the Executive on the 10<SUP>th</SUP>&nbsp;day of the month immediately following the month in which the Executive timely remits
the premium payment. The Executive shall be eligible to receive such reimbursement until the earliest of: (i) the twenty-four-month anniversary
of the termination; (ii) the date the Executive is no longer eligible to receive COBRA continuation coverage; and (iii) the date on which
the Executive becomes eligible to receive substantially similar coverage from another employer or other source. Notwithstanding the foregoing,
if the Corporation&rsquo;s making payments under this&nbsp;<I>Section 5.5(d)</I>&nbsp;would violate the nondiscrimination rules applicable
to non-grandfathered plans under the ACA, or result in the imposition of penalties under the ACA, the parties agree to reform this&nbsp;<I>Section
5.5(d)</I>&nbsp;in a manner as is necessary to comply with the ACA;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e) &nbsp;&nbsp;All outstanding
time-based equity-based compensation awards granted to the Executive during the Term of Employment shall become fully vested; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(f) &nbsp;&nbsp;All outstanding
performance-based equity compensation awards granted to the Executive during the Term of Employment shall remain outstanding and shall
vest or be forfeited in accordance with the terms of the applicable award agreements, if the applicable performance goals are satisfied.
The determination whether such performance goals are satisfied shall be in the sole discretion of the Compensation Committee or the Board,
as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt">Amounts owed pursuant to Sections
5.5(b)-(c) shall be paid in a lump sum within 30 calendar days following the effective date of the consummation of the Change in Control;
provided the Release is effective and non-revocable; further provided, however, that if such 30-day period spans two calendar years, payment
of any amounts determined to be deferred compensation subject to Section 409A of the Code shall be made or commence in the second calendar
year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.6&nbsp;<U>Release; Exclusive
Remedy</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) The Executive agrees that
the payments contemplated by this&nbsp;<I>Section 5</I>&nbsp;shall constitute the exclusive and sole remedy for any termination of her
employment and the Executive covenants not to assert or to pursue any other remedies, at law or in equity, with respect to any termination
of employment. The Corporation and Executive acknowledge and agree that there is no duty of the Executive to mitigate damages under this
Agreement. All amounts paid to the Executive pursuant to&nbsp;<I>Section 5</I>&nbsp;shall be paid without regard to whether the Executive
has taken or takes actions to mitigate damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) As used herein, &ldquo;<U>Release</U>&rdquo;
shall mean a written release, discharge and covenant not to sue entered into by the Executive in favor of the Corporation in the form
as in&nbsp;<U>Exhibit A</U>&nbsp;hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.7. <U>Death or Disability</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) The Executive&rsquo;s employment
hereunder shall terminate automatically upon the Executive&rsquo;s death during the Term of Employment, and the Corporation may terminate
the Executive&rsquo;s employment on account of the Executive&rsquo;s Disability consistent with applicable law. Executive will be eligible
for any employee plans in place that cover Disability and will be eligible for any employee benefits consistent with those plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) If the Executive&rsquo;s employment
is terminated during the Term of Employment on account of the Executive&rsquo;s death or Disability, the Executive (or the Executive&rsquo;s
estate and/or beneficiaries, as the case may be) shall be entitled to receive the Accrued Amounts. In addition, Executive&rsquo;s spouse
or partner and other dependents shall be entitled to twelve (12) months of COBRA Premium Reimbursements upon timely request to the Corporation
for such benefits. All outstanding equity-based compensation awards granted to the Executive during the Term of Employment shall become
fully vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.8 <U>Notice of Termination</U>.
Any termination of the Executive&rsquo;s employment hereunder by the Corporation or by the Executive during the Term of Employment (other
than termination pursuant to <I>Section 5.7</I> on account of the Executive&rsquo;s death) shall be communicated by written notice of
termination (the &ldquo;<U>Notice of Termination</U>&rdquo;) to the other party hereto in accordance with <I>Section 14(j)</I>. The Notice
of Termination shall specify:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The termination provision of this Agreement relied upon;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent applicable, the facts and circumstances claimed to provide a basis for termination of the Executive&rsquo;s employment under the provisions so indicated; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The applicable Termination Date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.9 <U>Termination Date</U>. The
Executive&rsquo;s Termination Date shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Executive&rsquo;s employment hereunder terminates on account of the Executive&rsquo;s death, the date of the Executive&rsquo;s death;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Executive&rsquo;s employment hereunder is terminated on account of the Executive&rsquo;s Disability, the date that it is determined that the Executive has a Disability;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Corporation terminates the Executive&rsquo;s employment hereunder for Cause, the date the Notice of Termination is delivered to the Executive;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Corporation terminates the Executive&rsquo;s employment hereunder without Cause, the date specified in the Notice of Termination, which shall be no less than 90 calendar days following the date on which the Notice of Termination is delivered; provided that, the Corporation shall have the option to provide the Executive with a lump sum payment equal to 90 calendar days&rsquo; Base Salary in lieu of such notice, which shall be paid in a lump sum on the Executive&rsquo;s Termination Date and for all purposes of this Agreement, the Executive&rsquo;s Termination Date shall be the date on which such Notice of Termination is delivered; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Executive terminates her employment hereunder with or without Good Reason, the date specified in the Executive&rsquo;s Notice of Termination, which shall be no less than 90 calendar days following the date on which the Notice of Termination is delivered.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notwithstanding anything contained herein, the Termination
Date shall not occur until the date on which the Executive incurs a Separation from Service within the meaning of Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.10 <U>Equity</U>. Upon termination
under this <I>Section 5</I> for any reason, Executive&rsquo;s outstanding and vested equity awards shall remain exercisable for twenty-four
(24) months following termination, subject to the provisions of the Corporation&rsquo;s equity incentive plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.11 <U>Resignation From Boards
and Committees</U>. Following any termination of Executive&rsquo;s employment as Chief Executive Officer with the Corporation, Executive
agrees to resign, as of the date of such termination, from (i) each and every board of directors (or similar body, as the case may be)
of the Corporation and each of its affiliates on which Executive may then serve, including, but not limited to, the Board (and any committees
thereof), and (ii) each and every office of the Corporation and each of its affiliates that the Executive may then hold, and all positions
that he may have previously held with the Corporation and any of its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.12 <U>Section 409A of the Internal
Revenue Code.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) This Agreement is intended
to comply with Section 409A of the Internal Revenue Code of 1986 (&ldquo;<U>Section 409A</U>&rdquo;) and shall be construed and interpreted
consistent with that intent. Executive shall notify the Corporation in writing of any claim by the Internal Revenue Service or state tax
authorities that, if successful, would require the payment of any such Section 409A Penalties or related state tax statutes. Executive&rsquo;s
right to be put in an equivalent after tax economic position is subject to the Executive providing such notification no later than ten
(10) business days after Executive is informed in writing of such claim. If the Corporation desires to contest such claim, Executive shall
(i) cooperate with the Corporation in good faith in order to effectively contest such claim and (ii) permit the Corporation to participate
in any proceedings relating to such claim. The Corporation shall control all proceedings taken in connection with such contest; provided,
however, that the Corporation shall bear and pay directly all costs and expenses (including additional interest and penalties) incurred
in connection with such contest. This section shall also apply to any taxes, penalties, or interest imposed by any state that are calculated
in a manner similar to taxes, penalties, or interest imposed by Section 409A(a)(1)(B), including those amounts imposed by the State of
Colorado tax laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) If and to the extent that
any payment or benefit under this Agreement, or any plan or arrangement of the Corporation, is determined by the Corporation to constitute
&ldquo;non-qualified deferred compensation&rdquo; subject to Section 409A and is payable to the Executive by reason of the Executive&rsquo;s
termination of employment, then (a) such payment or benefit shall be made or provided to the Executive only upon a &ldquo;separation from
service&rdquo; as defined for purposes of Section 409A under applicable regulations (a &ldquo;<U>Separation from Service</U>&rdquo;) and
(b) if the Executive is a &ldquo;specified employee&rdquo; (within the meaning of Section 409A and as determined by the Corporation),
such payment or benefit shall not be made or provided before the date that is six (6) months after the date of the Executive&rsquo;s Separation
from Service (or the Executive&rsquo;s earlier death). For the purposes of clarity, the first payment thereof will include a catch-up
payment covering the amount that would have otherwise been paid to the Executive during the period between the termination of Executive&rsquo;s
employment and the first payment date but for the application of this provision, and the balance of the installments (if any) will be
payable in accordance with their original schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) To the extent any expense
reimbursement or in-kind benefit is determined to be subject to Section 409A, the amount of any such expenses eligible for reimbursement
or in-kind benefits provided in one taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits provided
in any other taxable year (except under any lifetime limit applicable to expenses for medical care), in no event shall any expenses be
reimbursed after the last day of the calendar year following the calendar year in which the Executive incurred such expenses, and in no
event shall any right to reimbursement or in-kind benefits be subject to liquidation or exchange for another benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d) To the extent that any provision
of this Agreement is ambiguous as to its compliance with Section 409A, the provision will be read in such a manner so that all payments
hereunder comply with Section 409A. To the extent any payment under this Agreement may be classified as a &ldquo;short-term deferral&rdquo;
within the meaning of Section 409A, such payment shall be deemed a short-term deferral, even if it may also qualify for an exemption from
Section 409A under another provision of Section 409A. Payments pursuant to this section are intended to constitute separate payments for
purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">6. <U>Non-Competition</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt">The Executive acknowledges and
recognizes the highly competitive nature of the businesses of the Corporation, the amount of sensitive and confidential information involved
in the discharge of the Executive&rsquo;s position with the Corporation, and the harm to the Corporation that would result if such knowledge
or expertise was disclosed or made available to a competitor. Based on that understanding, the Executive hereby expressly agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 40.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) As a result of the particular
nature of the Executive&rsquo;s relationship with the Corporation, in the capacities identified earlier in this Agreement, for the Term
of Employment, the Executive hereby agrees that Executive will not, directly or indirectly, (i) engage in any business for the Executive&rsquo;s
own account or otherwise derive any personal benefit from any business that competes with the business of the Corporation or any of its
affiliates (the Corporation and its affiliates are referred to, collectively, as the &ldquo;<U>Company Group</U>&rdquo;), (ii) enter the
employ of, or render any services to, any person engaged in any business that competes with the business of any entity within the Company
Group, (iii) acquire a financial interest in any person engaged in any business that competes with the business of any entity within the
Company Group, directly or indirectly, as an individual, partner, member, shareholder, officer, director, principal, agent, trustee or
consultant, or (iv) interfere with business relationships (whether formed before or after the Effective Date) between the Corporation,
any of its respective affiliates or subsidiaries, and any customers, suppliers, officers, employees, partners, members or investors of
any entity within the Company Group. For purposes of this Agreement, businesses in competition with the Company Group shall include, without
limitation, businesses which any entity within the Company Group may conduct operations, and any businesses which any entity within the
Company Group has specific plans to conduct operations in the future and as to which the Executive is aware of such planning, whether
or not such businesses have or have not as of that date commenced operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) Notwithstanding anything to
the contrary in this Agreement, the Executive may, directly or indirectly, own, solely as an investment, securities of any Person, other
than a business that competes with the business of the Company Group, which are publicly traded on a national or regional stock exchange
or on the over-the-counter market if the Executive (i) is not a controlling Person of, or a member of a group that controls, such Person,
and (ii) does not, directly or indirectly, beneficially own one percent (1%) or more of any class of securities of such Person. Executive
may indirectly, through a mutual or exchange traded fund, own, solely as an investment, securities of a business that competes with the
business of the Company Group, which are publicly traded on a national or regional stock exchange or on the over-the-counter market if
the Executive (i) is not a controlling Person of, or a member of a group that controls, such Person, and (ii) does not, directly or indirectly,
beneficially own one percent (1%) or more of any class of securities of such business. For purposes of this&nbsp;<I>Section 6(b)</I>,
&ldquo;<U>Person</U>&rdquo; shall have the meaning ascribed to such terms in Section 3(a)(9) of the Exchange Act and used in Sections
13(d) and 14(d) thereof, including a &ldquo;group&rdquo; as described in Section 13(d) thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">7.&nbsp;<U>Confidential Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As a material part of the consideration
for the Corporation&rsquo;s commitment to the terms of this Agreement, the Executive hereby agrees that the Executive will not at any
time (whether during or after the Executive&rsquo;s employment with the Corporation), other than in the course of the Executive&rsquo;s
duties hereunder, or unless compelled by lawful process after written notice to the Corporation of such notice along with sufficient time
for the Corporation to try and overturn such lawful process, disclose or use for the Executive&rsquo;s own benefit or purposes or the
benefit or purposes of any other person, firm, partnership, joint venture, association, corporation or other business organization, entity
or enterprise, any trade secrets, or other confidential data or information relating to customers, development programs, costs, marketing,
trading, investment, sales activities, promotion, credit and financial data, financing methods, or plans of any entity within the Company
Group;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that the foregoing shall not apply to information which is generally known to the industry
or the public, other than as a result of the Executive&rsquo;s breach of this covenant. The Executive further agrees that the Executive
will not retain or use for Executive&rsquo;s own account, at any time, any trade names, trademark or other proprietary business designation
used or owned in connection with the business of any entity within the Company Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">8. <U>Proprietary Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) <U>Inventions</U>. All inventions,
policies, systems, developments or improvements conceived, designed, implemented and/or made by Executive, either alone or in conjunction
with others, at any time or at any place during the Term of Employment, whether or not reduced to writing or practice during such Term
of Employment, which directly or indirectly relate to the business of any entity within the Company Group, or which were developed or
made in whole or in part using the facilities and/or capital of any entity within the Company Group, shall be the sole and exclusive property
of the Company Group. Executive shall promptly give notice to the Corporation of any such invention, development, patent or improvement,
and shall at the same time, without the need for any request by any person or entity within the Company Group, assign all of Executive&rsquo;s
rights to such invention, development, patent and/or improvement to the Company Group. Executive shall sign all instruments necessary
for the filing and prosecution of any applications for, or extensions or renewals of, letters patent of the United States or any foreign
country that any entity in the Company Group desires to file.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) <U>Work Product</U>. Executive
acknowledges and agrees that all writings, works of authorship, technology, inventions, discoveries, ideas and other work product of any
nature whatsoever, that are created, prepared, produced, authored, edited, amended, conceived or reduced to practice by the Executive
individually or jointly with others during the Term of Employment by the Corporation and relating in any way to the business or contemplated
business, research or development of the Corporation (regardless of when or where the Work Product is prepared or whose equipment or other
resources is used in preparing the same) and all printed, physical and electronic copies, all improvements, rights and claims related
to the foregoing, and other tangible embodiments thereof (collectively, &ldquo;<U>Work Product</U>&rdquo;), as well as any and all rights
in and to copyrights, trade secrets, trademarks (and related goodwill), patents and other intellectual property rights therein arising
in any jurisdiction throughout the world and all related rights of priority under international conventions with respect thereto, including
all pending and future applications and registrations therefor, and continuations, divisions, continuations-in-part, reissues, extensions
and renewals thereof (collectively, &ldquo;<U>Intellectual Property Rights</U>&rdquo;), shall be the sole and exclusive property of the
Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For purposes of this Agreement,
Work Product includes, but is not limited to, Company Group information, including plans, publications, research, strategies, techniques,
agreements, documents, contracts, terms of agreements, negotiations, know-how, computer programs, computer applications, software design,
web design, work in process, databases, manuals, results, developments, reports, graphics, drawings, sketches, market studies, formulae,
notes, communications, algorithms, product plans, product designs, styles, models, audiovisual programs, inventions, unpublished patent
applications, original works of authorship, discoveries, experimental processes, experimental results, specifications, customer information,
client information, customer lists, client lists, manufacturing information, marketing information, advertising information, and sales
information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) <U>Work Made for Hire; Assignment</U>.
All copyrightable work by Executive during the Term of Employment that relates to the business of any entity in the Company Group is intended
to be &ldquo;work made for hire&rdquo; as defined in Section 101 of the Copyright Act of 1976, and shall be the property of the Company
Group. If the copyright to any such copyrightable work is not the property of the Company Group by operation of the law, Executive will,
without further consideration, assign to the Company Group all right, title and interest in such copyrightable work and will assist the
entities in the Company Group and their nominees in every way, at the Company Group&rsquo;s expense, to secure, maintain and defend for
the Company Group&rsquo;s benefit, copyrights and any extensions and renewals thereof on any and all such work including translations
thereof in any and all countries, such work to be and to remain the property of the Company Group whether copyrighted or not.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d) <U>Further Assurances; Power
of Attorney</U>. During and after the Term of Employment, Executive agrees to reasonably cooperate with the Corporation to (i) apply for,
obtain, perfect and transfer to the Company Group the Work Product as well as an Intellectual Property Right in the Work Product in any
jurisdiction in the world; and (ii) maintain, protect and enforce the same, including, without limitation, executing and delivering to
the Corporation any and all applications, oaths, declarations, affidavits, waivers, assignments and other documents and instruments as
shall be requested by the Corporation. Executive hereby irrevocably grants the Corporation power of attorney to execute and deliver any
such documents on Executive&rsquo;s behalf in the Executive&rsquo;s name and to do all other lawfully permitted acts to transfer the Work
Product to the Corporation and further the transfer, issuance, prosecution and maintenance of all Intellectual Property Rights therein,
to the full extent permitted by law, if Executive does not promptly cooperate with the Corporation&rsquo;s request (without limiting the
rights the Corporation shall have in such circumstances by operation of law). The power of attorney is coupled with an interest and shall
not be affected by Executive&rsquo;s subsequent incapacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e) <U>No License</U>. Executive
understands that this Agreement does not, and shall not be construed to, grant the Executive any license or right of any nature with respect
to any Work Product or Intellectual Property Rights or any Confidential Information, materials, software or other tools made available
to the Executive by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">9.&nbsp;<U>Anti-Solicitation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In light of the amount of sensitive
and confidential information involved in the discharge of the Executive&rsquo;s duties, and the harm to the Corporation that would result
if such knowledge or expertise were disclosed or made available to a competitor, and as a reasonable step to help protect the confidentiality
of such information, the Executive promises and agrees that during the Term of Employment and for a period of two (2) years thereafter,
the Executive will not use the Corporation&rsquo;s confidential information to, directly or indirectly, individually or as a consultant
to, or as an employee, officer, shareholder, director or other owner or participant in any business, influence or attempt to influence
the customers, vendors, suppliers, joint venturers, associates, consultants, agents, or partners of any entity within the Company Group,
either directly or indirectly, to divert their business away from the Company Group, to any individual, partnership, firm, corporation
or other entity then in competition with the business of any entity within the Company Group, and he will not otherwise materially interfere
with any business relationship of any entity within the Company Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">10.&nbsp;<U>Non-Solicitation of Employees</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In light of the amount of sensitive
and confidential information involved in the discharge of the Executive&rsquo;s duties, and the harm to the Corporation that would result
if such knowledge or expertise were disclosed or made available to a competitor, and as a reasonable step to help protect the confidentiality
of such information, the Executive promises and agrees that during the Term of Employment and for a period of one (1) year thereafter,
the Executive will not, directly or indirectly, individually or as a consultant to, or as an employee, officer, shareholder, director,
or other owner of or participant in any business, solicit (or assist in soliciting) any person who is then, or at any time within six
(6) months prior thereto was, an employee of an entity within the Company Group, who earned annually $25,000 or more as an employee of
such entity during the last six (6) months of his or her own employment to work for (as an employee, consultant or otherwise) any business,
individual, partnership, firm, corporation, or other entity whether or not engaged in competitive business with any entity in the Company
Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">11. <U>Non-Disparagement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Executive agrees and covenants that Executive shall
not at any time make, publish, or communicate to any person or entity or in any public forum any defamatory, or maliciously false, or
disparaging remarks, comments, or statements concerning the Company Group or its businesses, or any of its employees, officers, or directors
and their existing and prospective customers, suppliers, investors, and other associated third parties, now or in the future; provided
that nothing in this Agreement prohibits Executive from disclosing information about unlawful acts in the workplace, including harassment
or discrimination or any other conduct you have reason to believe is unlawful, or from disclosing information about the underlying facts
of any alleged discriminatory or unfair employment practice or the terms of this Agreement to the Employee&rsquo;s immediate family members,
religious advisors, medical or mental health providers, mental or behavioral health therapeutic support groups, legal counsel, financial
advisors, or tax preparers; to any local, state, or federal government for any reason; in response to any legal process, such as a subpoena
or court proceeding; or for any other purpose required by law. Disclosure of the underlying facts of an alleged discriminatory or unfair
employment practice does not constitute disparagement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Corporation agrees and covenants that the Corporation
shall not at any time make, publish, or communicate, and shall direct its executive officers and directors not to make publish or communicate,
to any person or entity or in any public forum any defamatory, or maliciously false, or disparaging remarks, comments, or statements concerning
Executive; provided that nothing in this Agreement the Company&rsquo;s ability to respond with truthful information regarding Executive&rsquo;s
termination in response to inquiries from any state unemployment insurance agency, in legally required public filings, or in any legal
or administrative proceeding, or to comply with any other obligations under federal, state, or local law.&nbsp; In the event that the
Corporation disparages Executive to a third party, the Corporation may not seek to enforce these Section 11&nbsp;non-disparagement&nbsp;provisions
against Executive, but all other remaining terms of the Agreement shall remain enforceable.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">12. <U>Return of Property</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Executive agrees to truthfully
and faithfully account for and deliver to the Corporation all property belonging to the Corporation, any other entity in the Company Group,
or any of their respective affiliates, which Executive may receive from or on account of the Corporation, any other entity in the Company
Group, or any of their respective affiliates, and upon the termination of the Term of Employment, or the Corporation&rsquo;s demand, Executive
shall immediately deliver to the Corporation all such property belonging to the Corporation, any other entity in the Company Group, or
any of their respective affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">13. <U>Withholding Taxes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything else
herein to the contrary, the Corporation may withhold (or cause there to be withheld, as the case may be) from any amounts otherwise due
or payable under or pursuant to this Agreement such federal, state and local income, employment, or other taxes as may be required to
be withheld pursuant to any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">14. <U>Cooperation in Litigation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Executive agrees that, during
the Term of Employment or after the termination of Executive&rsquo;s employment, Executive will reasonably cooperate with the Corporation,
subject to Executive&rsquo;s reasonable personal and business schedules, in any litigation which arises out of events occurring prior
to the termination of Executive&rsquo;s employment, including but not limited to, serving as a witness or consultant and producing documents
and information relevant to the case or helpful to the Corporation. The Corporation agrees to reimburse Executive for all reasonable costs
and expenses Executive incurs in connection with her obligations under this <I>Section 9</I> and, in addition, to reasonably compensate
Executive for time actually spent in connection therewith following the termination of Executive&rsquo;s employment with the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">15. <U>Miscellaneous</U>.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(a) <U>Assignment</U>. This Agreement is personal
in its nature and neither of the parties hereto shall, without the consent of the other, assign or transfer this Agreement or any rights
or obligations hereunder; <U>provided</U>, <U>however</U>, that in the event of a merger, consolidation, or transfer or sale of all or
substantially all of the assets of the Corporation with or to any other individual(s) or entity, this Agreement shall, subject to the
provisions hereof, be binding upon and inure to the benefit of such successor and such successor shall discharge and perform all the promises,
covenants, duties, and obligations of the Corporation hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(b) <U>Number and Gender</U>. Where the context requires,
the singular shall include the plural, the plural shall include the singular, and any gender shall include all other genders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(c) <U>Section Headings</U>. The section headings
of, and titles of paragraphs and subparagraphs contained in, this Agreement are for the purposes of convenience only, and they neither
form a part of this Agreement nor are they to be used in the construction or interpretation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(d) <U>Governing Law</U>. This Agreement, and all
questions relating to its validity, interpretation, performance and enforcement, as well as the legal relations hereby created between
the parties hereto, shall be governed by and construed under, and interpreted and enforced in accordance with, the laws of the State of
Colorado, notwithstanding any Colorado or other conflict of law provision to the contrary. This Agreement is intended to comply with Section
409A of the Internal Revenue Code of 1986 and the regulations promulgated thereunder. Any action or proceeding by either of the parties
to enforce this Agreement shall be brought only in a state or federal court located in the State of Colorado, Boulder county. The parties
hereby irrevocably submit to the exclusive jurisdiction of such courts and waive the defense of inconvenient forum to the maintenance
of any such action or proceeding in such venue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(e) <U>Severability</U>. If any provision of this
Agreement or the application thereof is held invalid, the invalidity shall not affect other provisions or applications of this Agreement
which can be given effect without the invalid provisions or applications and to this end the provisions of this Agreement are declared
to be severable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(f) <U>Entire Agreement</U>. This Agreement embodies
the entire agreement of the parties hereto respecting the matters within its scope. Any prior negotiations, correspondence, agreements,
proposals or understandings relating to the subject matter hereof shall be deemed to have been merged into this Agreement, and to the
extent inconsistent herewith, such negotiations, correspondence, agreements, proposals, or understandings shall be deemed to be of no
force or effect. There are no representations, warranties, or agreements, whether express or implied, or oral or written, with respect
to the subject matter hereof, except as expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(g) <U>Modifications</U>. This Agreement may not be
amended, modified or changed (in whole or in part), except by a formal definitive written agreement expressly referring to this Agreement,
which agreement is executed by both of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(h) <U>Waiver</U>. Neither the failure nor any delay
on the part of a party to exercise any right, remedy, power or privilege under this Agreement shall operate as a waiver thereof, nor shall
any single or partial exercise of any right, remedy, power or privilege preclude any other or further exercise of the same or of any right,
remedy, power or privilege, nor shall any waiver of any right, remedy, power or privilege with respect to any occurrence be construed
as a waiver of such right, remedy, power or privilege with respect to any other occurrence. No waiver shall be effective unless it is
in writing and is signed by the party asserted to have granted such waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(i) <U>Resolution of Disputes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(i) Any controversy arising out
of or relating to Executive&rsquo;s employment (whether or not before or after the expiration of the Term of Employment), any termination
of Executive&rsquo;s employment, this Agreement or the enforcement or interpretation of this Agreement, or because of an alleged breach,
default, or misrepresentation in connection with any of the provisions of this Agreement, including (without limitation) any state or
federal statutory claims, shall be submitted to arbitration in Denver, Colorado, before a sole arbitrator (the &ldquo;<U>Arbitrator</U>&rdquo;)
selected from the American Arbitration Association (&ldquo;<U>AAA</U>&rdquo;), and shall be conducted in accordance with the provisions
of Colorado Revised Uniform Arbitration Act as the exclusive remedy of such dispute; <U>provided</U>, <U>however</U>, that provisional
injunctive relief may, but need not, be sought in a court of law while arbitration proceedings are pending, and any provisional injunctive
relief granted by such court shall remain effective until the matter is finally determined by the Arbitrator. Final resolution of any
dispute through arbitration may include any remedy or relief that the Arbitrator deems just and equitable, including any and all remedies
provided by applicable state or federal statutes. At the conclusion of the arbitration, the Arbitrator shall issue a written decision
that sets forth the essential findings and conclusions upon which the Arbitrator&rsquo;s award or decision is based. Any award or relief
granted by the Arbitrator hereunder shall be final and binding on the parties hereto and may be enforced by any court of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(ii) The parties acknowledge and
agree that they are hereby waiving any rights to trial by jury in any action, proceeding or counterclaim brought by either of the parties
against the other in connection with any matter whatsoever arising out of or in any way connected with any of the matters referenced in
the first sentence of <I>Section 15(i)(i)</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(iii) The parties agree that the
Corporation shall be responsible for payment of the forum costs of any arbitration hereunder, including the Arbitrator&rsquo;s fee. The
parties further agree that in any proceeding with respect to such matters, the prevailing party will be entitled to recover its reasonable
attorney&rsquo;s fees and costs from the non-prevailing party (other than forum costs associated with the arbitration which in any event
shall be paid by the Corporation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(iv) Without limiting the
remedies available to the parties and notwithstanding the foregoing provisions of this <I>Section 15</I>, the Executive and the
Corporation acknowledge that any breach of any of the covenants or provisions contained in <I>Sections 6 through 11</I> could result
in irreparable injury to either of the parties hereto for which there might be no adequate remedy at law, and that, in the event of
such a breach or threat thereof, the non-breaching party shall be entitled to obtain a temporary restraining order and/or a
preliminary injunction and a permanent injunction restraining the other party hereto from engaging in any activities prohibited by
any covenant or provision in <I>Sections 6 through 11</I> or such other equitable relief as may be required to enforce specifically
any of the covenants or provisions of <I>Sections 6 through 11</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(j) <U>Publicity</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Executive hereby irrevocably consents
during the term of this Agreement to any and all uses and displays, by the Company Group and its agents, representatives and licensees,
of Executive&rsquo;s name, voice, likeness, image, appearance and biographical information in, on or in connection with any pictures,
photographs, audio and video recordings, digital images, websites, television programs and advertising, other advertising and publicity,
sales and marketing brochures, books, magazines, other publications, CDs, DVDs, tapes and all other printed and electronic forms and media
throughout the world, at any time during or after the period of Executive&rsquo;s employment by the Corporation, for all legitimate commercial
and business purposes of the Company Group (&rdquo;<U>Permitted Uses</U>&rdquo;) without further consent from or royalty, payment or other
compensation to the Executive. The Executive hereby forever waives and releases the Company Group and its directors, officers, employees
and agents from any and all claims, actions, damages, losses, costs, expenses and liability of any kind, arising under any legal or equitable
theory whatsoever at any time during or after the period of Executive&rsquo;s employment by the Corporation, arising directly or indirectly
from the Company Group&rsquo;s and its agents&rsquo;, representatives&rsquo; and licensees&rsquo; exercise of their rights in connection
with any Permitted Uses. At the end of the term of this Agreement, the Corporation shall have no obligation to remove any previously-published
displays described in this paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(k) <U>Notices</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(i) All notices, requests, demands
and other communications required or permitted under this Agreement shall be in writing and shall be deemed to have been duly received
if (i) delivered by hand or by courier, effective upon delivery, (ii) given by facsimile or electronic version, when transmitted if transmitted
on a business day and during normal business hours of the recipient, and otherwise delivered on the next business day following transmission,
or (iii) sent by registered or certified mail, postage prepaid, return receipt requested, 5 business days after being deposited in the
U.S. postal mail. Any notice shall be duly addressed to the parties as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">(i) If to the Corporation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Sonoma Pharmaceuticals, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Lead Independent Director of the Board or any Independent Director<BR>
5445 Conestoga Court, Suite 150<BR>
Boulder, Colorado 80301</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">(ii) If to the Executive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Amy Trombly<BR>
At the address on file with the Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(ii) Any party may alter the address
to which communications or copies are to be sent by giving notice of such change of address in conformity with the provisions of this
<I>Section 13</I> for the giving of notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(l) <U>Legal Counsel; Mutual Drafting</U>. Each party
recognizes that this is a legally binding contract and acknowledges and agrees that they have had the opportunity to consult with legal
counsel of their choice. Each party has cooperated in the drafting, negotiation and preparation of this Agreement. Hence, in any construction
to be made of this Agreement, the same shall not be construed against either party on the basis of that party being the drafter of such
language.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(m) <U>Provisions that Survive Termination</U>. The
provisions of <I>Sections 3.4</I>, <I>3.5</I>, <I>5</I> through 11, 14 and this <I>Section 15</I> shall survive any termination of the
Term of Employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(n) <U>Counterparts</U>. This Agreement may be executed
in any number of counterparts, each of which shall be deemed an original as against any party whose signature appears thereon, and all
of which together shall constitute one and the same instrument. This Agreement shall become binding when one or more counterparts hereof,
individually or taken together, shall bear the signatures of all of the parties reflected hereon as the signatories. Photographic copies
of such signed counterparts may be used in lieu of the originals for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(o) <U>Tolling</U>. Should the Executive violate any
of the terms of the restrictive covenant obligations articulated herein, the obligation at issue will run from the first date on which
the Executive ceases to be in violation of such obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[Signature Page Follows]<BR STYLE="clear: both"></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I></I></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Corporation and Executive
have executed this Amended and Restated Employment Agreement as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CORPORATION</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonoma Pharmaceuticals, Inc.,</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Delaware corporation</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 51%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Jerry McLaughlin</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Title:</P></TD>
    <TD STYLE="vertical-align: top; border-top: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jerry McLaughlin<BR>
Lead Independent Director of</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonoma Pharmaceuticals, Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Amy Trombly</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amy Trombly</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[Signature Page to Amended and Restated Employment
Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Addendum to Amended and Restated Employment Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 31.5pt">By signing this Addendum, both
Parties attest and agree that the terms of the Agreement, including the terms of the non-disclosure, non-disparagement, and confidentiality
provisions comply with each requirement of Colorado Revised Statute &sect; 24-34-407(1) concerning Executive&rsquo;s disclosure of any
alleged discriminatory or unfair employment practice and all other statutory requirements. This Addendum does not otherwise modify or
supersede the provisions of the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 31.5pt">Unless otherwise specified, capitalized
terms in this Addendum have the same meaning as defined in the Agreement, and those definitions are incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 31.5pt"><B>IN WITNESS WHEREOF</B>, the
Parties have executed this Addendum as of the date(s) shown below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CORPORATION</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonoma Pharmaceuticals, Inc.,</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Delaware corporation</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 52%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Jerry McLaughlin</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Title:</P></TD>
    <TD STYLE="vertical-align: top; border-top: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jerry McLaughlin<BR>
Lead Independent Director of</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonoma Pharmaceuticals, Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Amy Trombly</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amy Trombly</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B></B></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>EXHIBIT A &mdash; RELEASE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">1.&nbsp;<U>Definitions</U>. I
intend all words used in this Release to have their plain meanings in ordinary English. Technical legal words are not needed to describe
what I mean. Specific terms I use in this Release have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A. &ldquo;I,&rdquo; &ldquo;me,&rdquo;
and &ldquo;my&rdquo; include me, Amy Trombly, and anyone who has or obtains any legal rights or claims through me, including my heirs
and estate, and each of my descendants, dependents, executors, administrators, assigns and successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">B. &ldquo;Employer,&rdquo; as
used in this Release, shall at all times mean Sonoma Pharmaceuticals, Inc. and &ldquo;Released Party&rdquo; or &ldquo;Released Parties&rdquo;,
individual and collectively, means the Employer and the Employer&rsquo;s parent, past or present subsidiaries, affiliates, each of any
present or former officers, directors, shareholders, employees, agents or attorneys, trustees, insurers, successors, predecessors, assigns,
or personal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">C. &ldquo;My Claims&rdquo; mean
actions or causes of action, suits, claims, charges, complaints, contracts (whether oral or written, express or implied from any source),
and promises, whatsoever, in law or equity, that I ever had, may now have or hereafter can, shall or may have against the Employer or
other Released Party as of the date of the execution of this Release, including all unknown, undisclosed and unanticipated losses, wrongs,
injuries, debts, claims or damages to me for, upon, or by reason of any matter, cause or thing whatsoever, that are in any way related
to my employment with or separation (termination of employment) from the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">By signing this Release, I am
agreeing to release any actual and potential claim, known or unknown, I have or may potentially have, in law or in equity, either as an
individual or standing in the shoes of the government, under any federal, state or local law, administrative regulation or legal principle
(except as provided in Paragraph 4 of this Release). The following listing of laws and types of claims is not meant to, and shall not
be interpreted to, exclude any particular law or type of claim, law, regulation or legal principle not listed. I understand I am releasing
all my Claims, including, but not limited to, claims for invasion of privacy; breach of written or oral, express or implied, &#9;contract;
fraud or misrepresentation; and any claim under Section 1981 of the Civil Rights Act of 1866, Title VII of the Civil Rights Act of 1964,
Age Discrimination in Employment Act of 1967 (&ldquo;ADEA&rdquo;), 29 U.S.C. &sect; 626, as amended, the Older Workers Benefit Protection
Act of 1990 (&ldquo;OWBPA&rdquo;), 29 U.S.C. 626(f), Title VII of the Civil Rights Act of 1964 (&ldquo;Title VII&rdquo;), 42 U.S.C. &sect;
2000e, et seq., the Americans with Disabilities Act Amendments Act (&ldquo;ADAAA&rdquo;), 29 U.S.C. &sect; 2101, et seq., the Family and
Medical Leave Act (&ldquo;FMLA&rdquo;), 29 U.S.C. &sect; 2601 et seq., the Employee Retirement Income Security Act of 1974 (&ldquo;ERISA&rdquo;),
as amended, 29 U.S.C. &sect;&sect; 1001, et seq., Equal Pay Act (&ldquo;EPA&rdquo;), 29 U.S.C. &sect; 206(d), the Worker Adjustment and
Retraining Notification Act (&ldquo;WARN&rdquo;), 29 U.S.C. &sect; 2101 et seq., the False Claims Act, 31 U.S.C. &sect; 3729 et seq.,
the Colorado Anti-Discrimination Act (CADA), the Workplace Accommodations for Nursing Mothers Act, the Pregnant Workers Fairness Act,
the Lawful Off-Duty Activities Statute (LODA), the Personnel Files Employee Inspection Right Statute, the Colorado Labor Peace Act, the
Colorado Labor Relations Act, the Colorado Equal Pay Act, the Colorado Minimum Wage Order, the Colorado Genetic Information Non-Disclosure
Act, any other state human rights or fair employment practices act, and any other federal, state, or local statute, law, rule, regulation,
ordinance or order. This includes, but is not limited to, claims for violation of any civil rights laws based on protected class status;
claims for assault, battery, defamation, intentional or negligent infliction of emotional distress, breach of the covenant of good faith
and fair dealing, promissory estoppel, negligence, negligent hiring, retention or supervision, retaliation, constructive discharge, violation
of whistleblower protection laws, unjust enrichment, payment of any kind, including any other claim for severance pay, bonus or incentive
pay, sick leave, holiday pay, vacation pay, life insurance, health or medical insurance or any other fringe benefit, medical expenses,
or disability, violation of public policy, and all other claims for unlawful employment practices, and all other common law or statutory
claims. To the maximum extent permitted by law, I agree that I will not seek and waive any right to accept any relief or award from any
charge or action against the Employer before any federal, state, or local administrative agency or federal state or local court whether
filed by me or on my behalf with respect to any claim or right covered by this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">2.&nbsp;<U>Agreement to Release
My Claims</U>. Except as stated in Paragraph 4, I agree to give up all My Claims, waive any rights thereunder, and forever discharge the
Employer and all Released Parties of and from any and all liability to me for actions or causes of action, suits, or Claims. To the maximum
extent permitted by law, I agree that I will not seek and I waive any right to accept any relief or award from any charge or action against
the Employer or other Released Party before any federal, state, or local administrative agency or federal state or local court whether
filed by me or on my behalf with respect to any claim or right covered by this Release. I also agree to withdraw any and all of my charges
and lawsuits against Employer or other Released Party, except that I may, but am not required to, withdraw or dismiss, or attempt to withdraw
or dismiss, any charges that I may have pending against the Employer or other Released Party with the EEOC or other civil rights enforcement
agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">I represent and warrant that I
have not transferred or otherwise assigned my Claims, or parts thereof, to any person or entity, other than the Employer. I will defend,
indemnify and hold harmless the Employer from and against any claim (including the payment of attorneys&rsquo; fees and costs actually
incurred whether or not litigation is commenced) that is directly or indirectly based on or in connection with or arising out of any such
assignment or transfer made, purported or claimed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In exchange for my agreement
to release my Claims, I am receiving satisfactory Consideration (compensation) from the Employer to which I am not otherwise entitled
by law, contract, or under any Employer policy. The consideration I am receiving is a full and fair payment for the release of all my
Claims. The Employer and the Released Parties do not owe me anything in addition to what I will be receiving.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">3.&nbsp;<U>Older Workers Benefit
Protection Act</U>. [This section may be revised if Executive terminates employment as part of a &ldquo;group&rdquo; termination.] The
Older Workers Benefit Protection Act (&ldquo;OWBPA&rdquo;) applies to individuals age 40 and older and sets forth certain criteria for
such individuals to waive their rights under the Age Discrimination in Employment Act (&ldquo;ADEA&rdquo;) in connection with an exit
incentive program or other employment termination program. I understand and have been advised that this Release of My Claims is subject
to the terms of the OWBPA. The OWBPA provides that an individual cannot waive a right or claim under the ADEA unless the waiver is knowing
and voluntary. I have been advised of this law, and I agree that I am signing this Release voluntarily, and with full knowledge of its
consequences. I understand that the Employer is giving me at least twenty-one (21) calendar days from the date I received a copy of this
Release to decide whether I want to sign it. I acknowledge that I have been advised to use this time to consult with an attorney about
the effect of this Release. If I sign this Release before the end of the twenty-one (21) day period it will be my personal, voluntary
decision to do so, and will be done with full knowledge of my legal rights. I agree that material and/or immaterial changes to the Separation
Agreement or this Release will not restart the running of this consideration period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">4.&nbsp;<U>Exclusions from Release</U>.
My Claims do not include my rights, if any, to claim the following: unemployment insurance or workers compensation benefits; claims for
my vested post-termination benefits under any 401(k) or similar tax-qualified retirement benefit plan; my COBRA rights; and my rights
to enforce the terms of this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A. Nothing in this Release interferes
with my right to file a charge with the Equal Employment Opportunity Commission (&ldquo;EEOC&rdquo;) or other local civil rights enforcement
agency, or participate in any manner in an EEOC investigation or proceeding under Title VII, the ADA, the ADEA, or the EPA. I, however,
understand that I am waiving my right to recover individual relief including, but not limited to, back pay, front pay, reinstatement,
attorneys&rsquo; fees, and/or punitive damages, in any administrative or legal action whether brought by the EEOC or other civil rights
enforcement agency, me or any other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">B. Nothing in this Release interferes
with my right to challenge the knowing and voluntary nature of this Release under the ADEA and/or OWBPA, if I have rights under such laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">C. I agree that the Employer and
the Released Parties reserve any and all defenses, which any of them has or might have against any claims brought by me. This includes,
but is not limited to, the Employer&rsquo;s or other Released Party&rsquo;s right to seek available costs and attorneys&rsquo; fees, and
to have any monetary award granted to me, if any, reduced by the amount of money that I received in consideration for this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">D. Nothing in this Release releases
any claims for indemnification by Executive pursuant to any indemnification agreement, statute or otherwise or claims for coverage under
any D&amp;O or other similar insurance policy.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">5.&nbsp;<U>Effective Date; Right
to Rescind or Revoke</U>. I understand that insofar as this Release relates to my rights under the Age Discrimination in Employment Act
(&ldquo;ADEA&rdquo;), it shall not become effective or enforceable until seven (7) calendar days after I sign it. I also have the right
to rescind (or revoke) this Release insofar as it extends to potential claims under the ADEA by written notice to Employer within seven
(7) calendar days following my signing this Release (the &ldquo;Rescission Period&rdquo;). Any such rescission (or revocation) must be
in writing and hand-delivered to Employer or, if sent by mail, postmarked within the applicable time period, sent by certified mail, return
receipt requested, and addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A. post-marked within the seven
(7) calendar day Rescission Period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">B. properly addressed to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">[INSERT NAME AND ADDRESS]; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">C. sent by certified mail, return
receipt requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">6.&nbsp;<U>I Understand the Terms
of this Release</U>. I have had the opportunity to read this Release carefully and understand all its terms. I have had the opportunity
to review this Release with my own attorney. In agreeing to sign this Release, I have not relied on any statements or explanations made
by the Employer or its attorneys. I understand and agree that this Release and the attached Agreement contain all the agreements between
the Employer (and any other Released Party) and me. We have no other written or oral agreements. I understand this Release is a very important
legal document and I agree to be bound by the terms of this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 46%">&nbsp;</TD>
    <TD STYLE="width: 53%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: ____________, 20__</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amy Trombly</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt"></P>

<!-- Field: Page; Sequence: 21; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>snoa-20251003.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaSHKaPty552aYkxvmRxfQnaHyIkVnEPqCd3TVwGsaIJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:SNOA="http://sonomapharma.com/20251003" elementFormDefault="qualified" targetNamespace="http://sonomapharma.com/20251003">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://sonomapharma.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="snoa-20251003_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="snoa-20251003_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>snoa-20251003_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>snoa-20251003_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="snoa-20251003.xsd#Cover" roleURI="http://sonomapharma.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sonomapharma.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 03, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  03,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SONOMA
PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001367083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0423298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5445
Conestoga Court<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boulder<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">759-9305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SNOA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="sonoma_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sonomapharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>snoa-20251003.xsd</File>
    <File>snoa-20251003_lab.xml</File>
    <File>snoa-20251003_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="sonoma_8k.htm">sonoma_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "sonoma_8k.htm": {
   "nsprefix": "SNOA",
   "nsuri": "http://sonomapharma.com/20251003",
   "dts": {
    "schema": {
     "local": [
      "snoa-20251003.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "snoa-20251003_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "snoa-20251003_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "sonoma_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://sonomapharma.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-10-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sonoma_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-10-03",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "sonoma_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001683168-25-007478-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-25-007478-xbrl.zip
M4$L#!!0    ( -N#25N2C\H'*0,  .X+   1    <VYO82TR,#(U,3 P,RYX
M<V2U5MMRVC 0?>],_T'U:\<VAI(V!)+)D!L-N102)GWJ"%L&#;+D2#*8OZ_D
M&Q<#!=KZ25Z=<W97NRN[>1$'!$P1%YC1EN%8%0,@ZC(/TU'+>.V;E_UVIV.
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MJ;0MU58Y1'O8,8Q)C=9/*G.<2T#NEE1*EX4282'B$JO>7KH1TM"QU/3G)3=
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M\ZG[1_[XM%:[A!](.,ED'MFYH-R@'&X6^;\)^7\\J.+QK-,&O4N5&P8Z!0S
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M(-.90N P9-HMX4.&8^_:,+%AJ:%G3TB/F?88N<>7*"-)SE[F0ZIOF&!TQ/#
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MY9V42 Z_2AY_#OG(K/X_4$L#!!0    ( -N#25LIOK#XX6H  "-P @ 1
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M033:I*TS_%I<$,3;QXV;<:IGNV)..YYEY;'I3W)[)_ECEA>!O?E9YT=DVSW
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M2:^?\]ZK613GD:3>">FCL'0HTR5]0#1!OY/H@3T>! -8M\2OU\4 GNS\)%$
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M^G1>YF22V@R1WY\G6]GVYL:A'*>-#?0LSARF*=BA=[>V,Q+^K2G%_H3%'CZ
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ML.R.3)RC"Y]TC3#64OI66-JQL/Q+@F(T[V*\1$/KZVSD9YE9[(R%8\7NGI@
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M!T]=0],Z6TX\EHG:V0%DR+FH'4,Y*+=YYR^T\5 J\K'5>> >+4R&/X^7><$
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MV2;44KTXA9C!E<4>3+;V'KK7!*V&^BCJZ9K\\BA":<VS*XQ4?J/D&NX8%V;
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M#*K>YR?3)5>42R<-+#X[F2ZYBERZS0W,[>L1K;*].X$!\&3GJ:[S]^=*<L^
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MA[1+=4A"_#6-:!!9J%?,JKI] $ZC&F%6.'":\Q6+--;4G'JFK>ZS9.#U*5]
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M<NT9/KGA0(AU0VB?A& $!9C"W:&YNRUTWP]D#ZAW6\+VFQM!\L#64(B_DV
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MQT[JU<?$-/]7GQ5M77QSDA&=-T;L:99Z8.VU:24]4=X4^1U)0<Y$D'C_8YB
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M.I0M6E>;DZS23_A-+'(T<8^NRC)SS$31;-+X&V)X#Z#UX';D3;,$+7EQ)<J
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MG<<2[Z0/'^T\<7_S7T&@*$6NA 0#A^*E>GZ-SJ*3_ZVTN+G13Q:_Z:=1;@L
M(B?G@0;75VHAX*E54!S!Y=ZX@N/#:93^%6EB8\BB!W9=,1F"'_FQ)'$V[I)D
M3K$\G:'U!6I!%&*+(RO:25.0715%Q(U!]I5D_\M@0?<*]"*S&!5\5W.^G7+U
MCX:=2<#1= R/O35X2Z7]L\*UVF*_L&N5N'O;[".\/#HOGQ@O'='\ZAH'I!5'
MO6LSU91V6;7-%I<?5NA0L$/&L(T/Y6/5KGVO-RVFB::K)VE1:XK<+!T(F9Y)
MXUJ1:"CCIA-YQ41^1"J:$WT?9IR0$&=)G.15(8BJTC#/^KP#YQI13JY=CESD
M/$#SPM&-@8*BIY9K2G;@ T?F(>=C"Q;FLO1Y?Y)G.N$4<$W<ZS;,&VM0IE*/
MITPY!!GQ0UW%L3E%\H4[N!=7D6#CQCE\_E\?'!]@[>Q7\=[]-]GC=KAQ0;?J
M9R[,A"EQ>,4SLBN_'^=^G/MQ[L>Y'^=^G/MQOGR<:(2S'(!/[QV W\(!^/3>
M 7CM;U6W$_V+YX=ODC\.C]X<?/B0_/'/@_<';W^%KM[/UH%M''1D87^=@SL1
MAY=@L_"3[PW7J$["S@ !J)0SE0Y<JL0K>OQ239'!N%_'C/27.;R\W<O]V5,)
M[O9W3#UTG2T5^5LP<+$CVO<_>/D6\WOS[]\]I"/[]>V;HW!*#Z2CZL_G3:K/
M8UX\?_GV_;NW[_>/#M^^$0L-+W_N;]XES[U[L:_MUIR50Y!>]2Y=WC*RY)4I
M4$-MPF[HU_F4W=UYLO>W-4/%,N3)WRYSPUZL?@YWY[-F_/CQI4[E^^;[_VOJ
M>I7\-GZ=+8]G17X5!V?_^FO)(ZP*"%.]A+<=H5KF9Q&_%SX$U;18WH]Z2MNE
MG4KO2#C;XZP\H*LXM+/NQ>!;O@YGO!9+O7P9<QWF<'4JP,'_.WCY^]'A?QQ<
MD0)P'7;O6TN(CE%YA?R)I$:8BW8%QWEY<U6I\7F;>9F;=>Y.J=UYG9(KKR*F
M<C7OO-1%W[_L_F7W+[M_V?W+KO9E%PZOM]5Y_KX /_^_+\V->=GY^^(&ODA0
MX8?[H,*W""K\<!]4^.;\Y6H3A/8G$^(CTL3HPB&$J\XGNN*\I>'RF4=[.T_$
MQN2</,GQ16!%=RCEU*7-C7>:^@?(.<44C9'UXG2T0?#>WE. L$''RJ)JB,FG
M]M]<3!UT>$!933X1Y,\<&>$1SH_O$,:IG5J?:^'[>H"W'P2V-/D[&OT]2QX^
M?O#H\8/'NS]L[6TSD*AVB>N7U?N).M363"&0\57-F#F,-\P=(Z997H>E^ LD
MIN<*P.%Q)3Q*<3#QQF9_6C*=5+3U2.'V1;/<C&"E+4[1 -;8;I.=@J/@,&YT
MMN0:POU=8-O]QBB(#TIXQ]D"R",DCM!'ABG/%NR[K>6@HDO G9NLU-[7W*_!
MI_!WNXYP'K#MZ2 )EMQ;6F,>4JGM$#MOX\Z?'<CU+&,H;&MWWT=ED5N*SKK-
MK#I%RZ&B.KW*+-%K'I0]>]+KO+3VA8/BY;K&<"]_J7\M&/@EL[D18>!OOK0K
M" U?-^*Q$>*':^R1"T67U^B'UR/B_.A:1YPOONN7$3<>'NTR(]/#(]Q'J[^$
M 5SLTM^:X/8WV9ES![U?QK54Z"XO(G_WSNNKG-'=R0&X;CM_=U(&;DJ4__Z=
M=_:=T=O."IW]>!\Z^Q:ALQ_O0V?7];9<2<0*;<O_WS\/7QP>)?O)W^>3K)D]
M2]X?O#[8_W  .(.O&LOZIIVG]G9TW-^?O_)1 8%T. 0$1VLT\'-*#*%Q,!?L
M#W\OD-8."5;@A18%^C9H2()#%XRICL8,!^4Q4(EWDB,SGI6,XR[ TO)RZ38N
M[10%9]1"%J.%=-8FA_S:G>2#=CS0N-PAIM6;E0N1>!16.ZF;#%3Z&:/N[]@^
MGX>I(J';#^;&?B*@P?;CE7W.MFX$/G^@RKG6E(!O.9U5C!P%?PAWZV@"K' %
MQP9&(4.3.^R@>=3-<8YF&WFMV,42R)9!+.3-?,5D0'28E0)VK-X8P.)P?(81
MT[/)G,BWD<9E^'>#R+!@:#7+\=@T#7U^1QK*O7 G+RD!IG8$D-%6#]UBBZ<#
M#'?Z3\N3PH5)SO+U) 'QZ(LF"4)HCI"( (:^SP&LSA]'2#\:.2\*J74$P6$.
M M1CU^+0A^P'+MJ](!:"6.<B:[0#"Z.[HW5NDT_R#!@_1!K3:5Z@PUL K,21
M<?LX^H56]9R!F"P.?P#.3QM5FUD%C-DF .A/+3@_P'ZT-1U]V-9T4OPU79!E
MS;_Q!(FVCL3MW+^4; 4C&@'R2GJO1CCU=X2*7SHJ_FV5O&0N8JD*1$$L8^R!
M4+.EMHBP[3*;90X681LCC.G0N!\"YUX0L^(O*X'>:\)FU]+H0'N[<L,$0::M
MDYQ^F=N6R-R_N5K68[.="O=:T,<Y]UKP/1$8!0_=?VWOA)7V%CY,N&7"+)ND
MC"%55J<BLK1#JZ#5C;&3<C$!EI4I_%_8S=/="B152'I&?!,[X6K[M_#.$,'/
M<8*@V2X-O"P!24CS6)::3:)Y1TO ->7C?,&) [;/Q&E=H8&*-$R6"S<Q(W\4
MW,16FE- Q,^Y%5?* /"IXL-+DT?;DT(:1J:)MO%FP'I&$?-[+-VV.)7!=2;E
M/N><0E%!A@1)+9QV@Y9+'L1PJX-.YY_>]G!2=J?OR/7K)E<Y\CA,LKDVM]4^
M\MK<Q/;'LHQ\4;62_R1'GR9,2))II#1UZ(@>Q.U^4 BAA[<'S:SU BGZ(Z#N
MRDAZ5)R:)"ASF@'3S"KCZ/\8?41+R8?QS4VT-W3JNT47%>NFW/#,ZQ72^OMX
M:0'":E5UT&6';@%ZHFR93V.SX+I]UY&:)O+.-MI('G=OV[:TD/%**FG(K:(I
MTP1$@6E7"UF$7J%<\JK !=' *6RO3I]O;C"6&2#J:B/]XE/IB:Z]N!D1#[!J
MM=U<#.#>G\K*SUPJCX^IH@'UH6PF;SU3AQ($+8/3S7#_7BH?=KQ%6Z=7VM)/
MIZD+G/*!GV2V+S>->Y*-B5!].SW;?+L2GCW$J-/D[__?3\\LDW^&+C'9DE'F
MB4^',K4JG[F>Z])16:C#@5K^]..>:S]$Q%8D[T6]1=-Y^GSOQZ=/<>5:VIC_
M.#P\\]&?GCY.D?%MDE<^ 4^;Q(4)G.[Q'Y(M%8/[KP[V;4NC-'GX4X+^#9"2
MDA7X].'3E"^%Y(8*,L5;J"G)'U7]$<V87YB2S+PV>5?335-$5C?23[MNI+=_
MO'@W.!2-L37=_HRUNE>Z7_C7/GX8KV!SX^'N[B[=>H/NT/_:T?;KI(B1RDER
MGADW[9HT+4*6%@;B5%A.0.1_^LW:WS]KMQ[N[>YU1OJ5?=W2N_LW,V$#];4!
M?PI?_.MOK\]\[]/=O?BU*C<,7?G6)GF2\@Q(3"(PDI$DH]V._>!W[.#]X0<_
M$MVDX&B[P^K@>[O1H@[^!:[X+EM%"S@8/EH[_]VG6Y-MF;F03;(_@: 00!+L
M#:W#=DY$SYVI(M)'@_RQ__[-.;O?W?R")(BP";PI31[M=7[TZ =ZC_V1(#FZ
M3-E]DAL/.C>*Y_.2""%8#NE^8YPGL/2K228*)-C-FV7-':9^8QU*IX!?O2-&
MR,"4]A+]FN4U=UC!(S*-U]GI=%DD;Z?3!Z^6<IRV2:1-W=UZ_=9-Y!TK]J4I
MDE]S=(%S%')8<K-L3)ZODOVU19G1Q;[.1C3C=T:6TJ:V%VGT]7M3Z/+<4MP3
M$6%TOON-3G:^G"=_P%/XMIZ(@A4\\ ]B(B0_:+*^!]^;JN3=EUQC9BJI=#QU
M"<,FF2U)-0D\ ^NRC1LH$<[5H*^(I73JQ71CMTBDUK(PH>QB2PK^)^XT7TOC
M4,U45B='(Z)(A>H::10!@[*<8(:GBV%)/6*=6]H"MH(T2R\@.N$9-L3>@O?1
MY]FRH%6.6+U=04N>9K*;*4OO$G^*4E.:8U+8##<PG1;YV*NIE3XT@8K"S1.]
MA Q[@.+?QU4UP9XC,QY[R]L_,5G!TEBLEP9)W>BNLEB8(G4# \[;3V*6U_P3
M:!>E51 XGUMRN/F;K,AU,1X G#@I3 @VQ5*_I19VN"$),2(UB#L76@'%>PMU
M#3PH,27)@ME<K7S7[][WK@ML%T<Z(M*GK/*3 LBD0#]&E4"Y%(6AA'N8\9KX
MBR8??R25AU70&>(G4$[Q!6DA0@7\KR*?&C'K,]ZB&6VFV!9S%1_N2]O;1HD9
M&XC>62R.4_>X[<XG]O_$BKI5&M.?-($D=9G^=^70F\/5"I$MRT(8T] EZ_T.
M'-&IVR[%WU(MW1EI0S///C%_().!W^?:B9'EQE?P,"RR.!1<7MRLQIB//":W
M1>3=X.O#+4C'HC>7*]OT%OMUBJ9 UMJFB3#A\#?:WG?(#I9PRH!F'_",CE8/
MQ\V82R#T%UU3 !W+VD1]!*1'YH6L=RX\I82&.S*D@$]%2:&K"#YNFZL* 5;:
M,I OI79%"TV!.V)7WH]ZU:->*-;\TWVL^5O$FG^ZCS7?PAOWT,=1H\[:RMG)
MG+0>$.T4X]Q$6KH9.XD"&5IQ&\P$;8))C/[F'2D=(:K-'-AO(9+=-B%V&I=8
M"5$4!>_LQF5$GYKT>PS[;L'.;YM<Q 5/W[T<5"$V-[Y<ASC\0BTB6:=$:&<
M[TU/!IWI-U>[P)X63>4)"^^:U*3NA8<L$5>-EHB=  5\*=V31=TZ;Y/8VXB#
MT-.;LZY-)E8VYT-TW6AA8[E9B,(+&R35$!IIK6TX4:L4RS/^,)M@(/$G(T3,
M-L!PH&3X:%WWNX.#MR_]4Y&A9V#SCHW -LC!WA&U[=!'(56)KVMV/_/6*\XM
M3I=[W4Y-K<UL?8VKQ#;1U=9SL4J:.-E6--/4$K7$/CEL1H89:$I.@X8KXVB,
M90]D/].I2SC9S$O4&6.>"-0FB%USQ6U$",H3)E'''+E-6W$!>&AJVM"N;0P^
M17\NB5LW;:/Q#_0DIU<L>1=\;%$]#*UM7I(WTO>>5(#)MFQEWJQI<N[]"Q(-
M\4W'743+=DE'JWNUBJ79E6R][6QO3XC;<*72E:9NM?<PEF\F=X6H2[ JZ8H)
M<4:4F5GYS9%#&]D*2%8#'.AUC;UNZ"2;:3;F<OB7) MS\'B)*B+63/8\_VL@
MD)BXSIZ'EC7ZV\)D7R" :66B#62D$D&SX2OW-G$'2#QI'$VD,V5N0S==%A*E
M8S>0)7#;TM.N6ULIS8F<G0P?2L7H*1&32M9SBAPBS%.BM@C03B:Y[5Y_&HCW
MD?%3O"/D]\BKC8-QFLT-'ZB!IU:4Q_]BYV6C'VL#JEJ1(O)IT-W(1K5IWH$'
M*.-$&>$0-L/BN*Z6"YM=$03#=_Y;.L:=%T:*?/]1] C-QHI<@OT^5 MEPB2/
M=Z6I>C%14FI,RYXK8F=H@HY,PG&=TWSR#!\#-8)N2_@:$!$K@I)]J&+:=K8'
M L(% FU# ;8A%IN!7>!8G+\0CDI2VN=>70@V.DPJT.<ZP5(64!"<(V-P,^0,
M?</(]_X:.M4?U[=9COZDB3&+Z@&4\/;+/>4_;2A:U:2L##80&2:XIZI,JPII
MY4"XC[0U\"=:(<H_J#$71/(ETDN+.:F*9=EF]6K'AO:CE=G@MX36)5H<ZOFT
MD4,Y!^ZUN4U!Y.-@%N;Z9>+EI*6BXV79J%W==/;;X;XX!D:#:/MBL*D63E_H
MBZ=T?JL'R'+<>@B,E:Q  B(R5U:-9^2<3W.H; M9,6@9M_(MDX,,V8D9TQ$X
M50#FBYB(6"_-F]5SW_S3;L@ <52<[LK;@RR]7M_/K'0Z2I*-2!40R\9P X%N
M^L$.^HL?RB2B'5<[AW]93BQI=?>%_>)T.RMB/*UCX_.52UU+/45L;F /&N7\
M)!^:RIZE_&S"2:7#!SN/\TIW8L*99\PB6)Y]S_%_]XD(]\;V4/_@<GX"U#5-
M*O*+=^8F&M2!5;)(7):E)F;PP[&(E5VX(W+KL9=;!\@K$> >OA:ZA2RI K>'
MU0=<7K%U6Z206*0>L.(O3"=*VOZ9KF_ 4J-XRJF*HU#-LC&5YED0"-G<H/%.
M#+)52$MJV@<A9[8_"%2JQ[M[6Q^W.0Q"8@-Y,FWVZ0%BIHS1@_"6#>3KKY'V
M7CYC-?'MB_?[NCC)*G%K97:M%F27;=^Y, !)J#>54PJCZ\>Y2\ @HAUC?C /
M?#SPCH#1BAO'V^P<T0[D^MN@-?)+LK'RAEF/2X(@&]^)>B>\U1]SCL7OS%9-
M?K1IA[0SI:GE7^)$R$M0G;7V.".Y&AO#=J60FTN+T6275_NID[=IHMKX >3Y
M(4*1IYSPN+G1E6DL.B&3-:G>;1?Z4+.@]B)?76/G9&*-X-/G*"?=:_CH\"<Z
M<++SBB.PM!]#QG!JV? "N\]!7\GW="VA.PXREUZF'CDK)$=<,="*)^LLM\SF
M1G!*B3VD>2?HRKUP[\CM>O&%MVN,)$)3BK/8JG9)I-DEBF[:85M=75%I@#50
M9O*JS$0:.JOS\"_>D6-YV5%<NF4-HJKUC&FXW6IU=EM'+;N[--L<+@2F<];2
MYK8J9\ZG&F6,.P]7$]ZNN>EFQ&QNK$F)&:R[6.-1==\[\A+W_4E&,G54&.LQ
MPXK6,A(6FK(&L%C2$9D(Q:M_#!>D*,5<5Z2J1&TFR[%U@=,/Y^C8S&ID!:U8
M.:93V\72"Y2Y:4<AO"/4>9=&O4B,_.'N?8S\&\3('^[>Q\AOX8U[M5XE46\S
MQQM7<0V A')LAC$Q=._=7"SK9JE>%/RN^W#FP4\U1S2.1U51KARKR3@,UDQD
M)J_^GLT7S]YZ^6;-06^&JM/]+K'.)X'U'W6E?"9)RRRQWYMFG)<<4GIO3JJ/
M1HO*>]XXVLIJFG$U3Y<FV'$MY5M?Y-?=W!BNG"!SW17+D '/F?C&K81#CFQ-
ML(Y"F@/9&4@<)>/QAZXK4,KT#B,O'H+LKOJ\=CM2ZXYL(5+/6[+=5<S=3M ,
M.35BPNOOU%$U756;;H6MAJ$5 :Z9?N342NCXM#6\ MJ1WA*"^OCABJ]D"R.Y
M*EY:A9C2[]CE9;=U)]G7<*.L5,UM7>Q88V!S)/&BH)]FA#E;ZV)&__-@0H:I
MY"Z$\T=U("EV''B&KDK*8\I>'*+=CV9BU\>*'D(-8SXV=HV*4RYUOT5,03PX
M\I;:D"5#F\*:X$(2$]A+I+FQDPERJN'8M=MTA[ #V%'6W^,U=)3T"...<$.R
MM!=U192&RB%',&UU-U;_7X=O/AR\/TK>[/]VD.R_>44,Z=7[@P\?_IM=GW=C
M#\BH_VP&<T<LRJ=>53A,?@\EOTF.X/SFTH]0V%@U@07H+)-'J\"7RY(TF\02
M:IS5!D&CE1:F^P K27GX]MG3?M9[542?Y+3\3BQ(7&2H7+9>"GJ1JI=: -V+
MG[G*9HDB,6Q )<Y/YS]EOXGYA,B!%FHA'X?S/;KY:IQ]9UTD S'DR*443-[N
M-?TV&\]H#C[FA6P2Q-<9[0./V&\:DL_MJ0&3CZ:Q%==CQ:Z>;8ETF)WD#V,7
MK@]V"G6#@7KJ8*@,(4>%E($5BGGID#*XW\5+/*G&2UN,&";*C@P9W?0^Z_:Y
MEM&5J\?L=ZZ'OK/ P?F?"0*Y#N/[@HVF'S^]8$/JKE<AP-R\V/RNNN\F;!JR
MT?\G^']I\G#W?_YG$%CS$@?^G[/_WSJDTK^R:U>\E1? 6;WTV0_2UN7 CM+_
M_1@[>"ZCQ]K]*^_D*R_DBMY[EKQ=L);P<_(:*4KWGNEOX)G>^ZJ>Z2OQ$Z\A
MY.]?O'WUGV"+W__SZ+?7S_]_4$L! A0#%     @ VX-)6Y*/R@<I P  [@L
M !$              ( !     '-N;V$M,C R-3$P,#,N>'-D4$L! A0#%
M  @ VX-)6R#[UB3]"@  ?X8  !4              ( !6 ,  '-N;V$M,C R
M-3$P,#-?;&%B+GAM;%!+ 0(4 Q0    ( -N#25O**5])6@<  -Q7   5
M          "  8@.  !S;F]A+3(P,C4Q,# S7W!R92YX;6Q02P$"% ,4
M" #;@TE;C$'>*]T7  !^A   #0              @ $5%@  <V]N;VUA7SAK
M+FAT;5!+ 0(4 Q0    ( -N#25LIOK#XX6H  "-P @ 1              "
L 1TN  !S;VYO;6%?97@Q,# Q+FAT;5!+!08     !0 % #\!   MF0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>sonoma_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="snoa-20251003.xsd" xlink:type="simple"/>
    <context id="AsOf2025-10-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367083</identifier>
        </entity>
        <period>
            <startDate>2025-10-03</startDate>
            <endDate>2025-10-03</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-10-03" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-10-03" id="Fact000004">0001367083</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-10-03" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-10-03" id="Fact000010">2025-10-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-10-03" id="Fact000011">SONOMA PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-10-03" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-10-03" id="Fact000013">001-33216</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-10-03" id="Fact000014">68-0423298</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-10-03" id="Fact000015">5445 Conestoga Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-10-03" id="Fact000016">Suite 150</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-10-03" id="Fact000017">Boulder</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-10-03" id="Fact000018">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-10-03" id="Fact000019">80301</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-10-03" id="Fact000020">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-10-03" id="Fact000021">759-9305</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-10-03" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-10-03" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-10-03" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-10-03" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-10-03" id="Fact000026">Common     Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-10-03" id="Fact000027">SNOA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-10-03" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-10-03" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
